IV Anticoagulants Flashcards
(40 cards)
Heparin MOA
Binds with antithrombin to inactivate factor II and X
Also inactivates IX, XI, and XII
Heparin onset
SQ-20-30 minutes
IV- immediately
Heparin PK/PD
No renal dose adjustment
Recommended anticoagulant in dialysis patients
Heparin VTE Treatment dose
80 units/kg IV, then 18 units/kg/hr IV
Heparin ACS treatment dose
60 units/kg IV, then 12 units/kg/hour IV
Heparin is dosed based on:
Total body weight
Heparin Titration
Stop at Q6 hour aPTT check after 2 aPTTs in range –> daily aPTT checks
Therapeutic heparin indications, monitoring of efficacy and monitoring of AE?
VTE, afib, ACS
aPTT/anti-Xa per protocol
Platelets, Hgb/Hct
Prophylaxis heparin indications, monitoring of efficacy and monitoring of AE?
VTE prevention
None
Platelets, Hgb/Hct
Lovenox (enoxaparin) MOA
Binds with antithrombin to inactivate X and II (mainly X)
Lovenox Onset and duration
Peaks 3-5 hrs
Last ~12 hours
Lovenox requires ____ and is dosed on ____
Renal adjustment
Total body weight
Lovenox Therapeutic used when and dose
ACS, VTE (PE/DVT)
1mg/kg SQ q12h
Lovenox Alt Dose
1.5 mg/kg SQ daily
Lovenox prevention of VTE dose for medical/surgical if CrCl greater than 30
40 mg SQ daily
Lovenox prevention of VTE/propylaxis dose for knee replacement if CrCl greater than 30
30 mg SQ BID
Lovenox therapeutic dose for medical/surgical if CrCl less than 30
What if CrCl greater than 30?
1 mg/kg SQ daily
1 mg/kg SQ Q12h
Lovenox prevention of VTE/propylaxis dose if CrCl less than 30
30 mg daily
Lovenox monitoring
Anti-Xa
Monitoring is indicated when used in:
Pregnancy
Extremes of weight (less than 45 or greater than 190 kg)
CrCl less than 30
High risk of bleeding or VTE
**Anti-Xa monitoring is ordered
4 hours after dose for peak concentration
dose adjustments = order after 4 hrs
Fragmin (dalteparin) MOA
Binds with anti-thrombin to inactivate factor X and II
Fragmin Onset and excretion
Peaks 1-2 hrs
Renally excreted
Fragmin Onset and excretion
Peaks 1-2 hrs
Renally excreted